Tiffany has spent over 15 years bringing innovative medical technology from benchtop to bedside. She leads the Global Center for Medical Innovation, the Southeast’s first medical device innovation center and works with university innovators, clinicians, entrepreneurs, industry, investors, and startups focused on innovation, patient care, and economic growth. In 2016, GCMI acquired T3 Labs, a proven industry leading preclinical CRO for the medical device industry. Together, these organizations help medical device companies de-risk new technologies in a methodical, transparent, more predictable way to decrease time to market.
Tiffany joined GCMI after ten years with two medical device startups. At Scientific Intake, she was VP of Business Development & Strategy focused on product development and global commercialization efforts. In 2002, she launched ACell as VP of Corporate Strategy & Finance, leading a broad range of initiatives, including regulatory, reimbursement, and the scientific advisory board. A former consultant & investment banker, she brings considerable experience in strategic planning, business development, operations, and financial analysis.
Tiffany serves on the Board of the Southeastern Medical Device Association (SEMDA) as Past President, the National Advisory Council on Innovation and Entrepreneurship (NACIE) at the US Department of Commerce, the Business Advisory Council at the Sheikh Zayed Pediatric Surgical Innovation Institute at Children’s National, and on the Advisory Board of the Digital Health Accelerator at University City Science Center in Philadelphia. She earned a BBA in International Business from Loyola University and an MBA from the Georgetown University.